Trial intelligence / Profile preview

Ciprofol vs propofol for induction of general anesthesia in hypertensive patients

ChiCTR2500103391Phase 4Not yet recruiting

Sponsor
Weifang People's Hospital
Start
May 2025
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in hypertension (HTN) (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Hemodynamics change. Planned start May 2025; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR2500103391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500103391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call